The European landscape has seen a unique evolution in the perception of psychedelics. Historically stigmatized, these substances are now be explored for their medical applications. From Switzerland, where clinical trials are underway, to the France, where open conversations is increasing, Europe stands out in this re-evaluation of copyright culture